NKGen Biotech (NKGN) Competitors $0.30 0.00 (0.00%) As of 07/3/2025 12:47 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NKGN vs. RPTX, BMEA, ACHL, ANRO, IMMX, PDSB, STRO, ANL, VTGN, and QNTMShould you be buying NKGen Biotech stock or one of its competitors? The main competitors of NKGen Biotech include Repare Therapeutics (RPTX), Biomea Fusion (BMEA), Achilles Therapeutics (ACHL), Alto Neuroscience (ANRO), Immix Biopharma (IMMX), PDS Biotechnology (PDSB), Sutro Biopharma (STRO), Adlai Nortye (ANL), VistaGen Therapeutics (VTGN), and Quantum Biopharma (QNTM). These companies are all part of the "pharmaceutical products" industry. NKGen Biotech vs. Its Competitors Repare Therapeutics Biomea Fusion Achilles Therapeutics Alto Neuroscience Immix Biopharma PDS Biotechnology Sutro Biopharma Adlai Nortye VistaGen Therapeutics Quantum Biopharma NKGen Biotech (NYSE:NKGN) and Repare Therapeutics (NASDAQ:RPTX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk. Do analysts rate NKGN or RPTX? Repare Therapeutics has a consensus target price of $4.50, indicating a potential upside of 228.47%. Given Repare Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Repare Therapeutics is more favorable than NKGen Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NKGen Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Repare Therapeutics 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is NKGN or RPTX more profitable? NKGen Biotech's return on equity of 0.00% beat Repare Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets NKGen BiotechN/A N/A -479.36% Repare Therapeutics N/A -78.12%-67.11% Which has more volatility and risk, NKGN or RPTX? NKGen Biotech has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500. Comparatively, Repare Therapeutics has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. Does the media refer more to NKGN or RPTX? In the previous week, Repare Therapeutics had 3 more articles in the media than NKGen Biotech. MarketBeat recorded 3 mentions for Repare Therapeutics and 0 mentions for NKGen Biotech. NKGen Biotech's average media sentiment score of 0.00 equaled Repare Therapeutics'average media sentiment score. Company Overall Sentiment NKGen Biotech Neutral Repare Therapeutics Neutral Do insiders & institutionals believe in NKGN or RPTX? 76.2% of NKGen Biotech shares are owned by institutional investors. Comparatively, 85.1% of Repare Therapeutics shares are owned by institutional investors. 10.4% of NKGen Biotech shares are owned by insiders. Comparatively, 11.5% of Repare Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has stronger earnings & valuation, NKGN or RPTX? NKGen Biotech has higher earnings, but lower revenue than Repare Therapeutics. Repare Therapeutics is trading at a lower price-to-earnings ratio than NKGen Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNKGen BiotechN/AN/A-$82.94M-$2.45-0.12Repare Therapeutics$53.48M1.10-$84.69M-$3.01-0.46 SummaryRepare Therapeutics beats NKGen Biotech on 8 of the 13 factors compared between the two stocks. Get NKGen Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for NKGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NKGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NKGN vs. The Competition Export to ExcelMetricNKGen BiotechBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$13.48M$205.22M$5.56B$20.72BDividend YieldN/AN/A5.24%3.72%P/E Ratio-0.06N/A27.6128.07Price / SalesN/A223.65417.3038.44Price / CashN/A22.4436.8922.53Price / Book-0.115.618.034.58Net Income-$82.94M-$96.61M$3.18B$985.54M7 Day Performance24.90%-0.57%2.93%2.79%1 Month Performance-10.45%-1.03%3.75%5.46%1 Year Performance-77.61%10.57%35.20%15.06% NKGen Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NKGNNKGen BiotechN/A$0.30flatN/A-77.1%$13.48MN/A-0.06N/AGap UpRPTXRepare Therapeutics2.1031 of 5 stars$1.44+3.6%$4.50+212.5%-56.9%$61.59M$53.48M-0.48180News CoverageBMEABiomea Fusion2.5834 of 5 stars$1.64-9.2%$21.40+1,208.9%-62.0%$61.43MN/A-0.4650ACHLAchilles TherapeuticsN/A$1.48flatN/AN/A$60.83MN/A-0.90250ANROAlto Neuroscience2.4209 of 5 stars$2.21+0.5%$8.50+284.6%-79.8%$59.83MN/A-0.94N/AIMMXImmix Biopharma3.1561 of 5 stars$2.15+3.8%$7.00+225.7%+4.3%$59.80MN/A-3.069PDSBPDS Biotechnology2.3498 of 5 stars$1.30-2.3%$9.00+592.3%-55.6%$59.06MN/A-1.3720News CoverageAnalyst ForecastSTROSutro Biopharma3.2139 of 5 stars$0.71-1.2%$6.11+767.3%-73.4%$58.95M$66.43M-0.23240ANLAdlai Nortye1.8255 of 5 stars$1.60+8.5%$9.00+464.3%-57.0%$58.86M$5M0.00127VTGNVistaGen Therapeutics1.3795 of 5 stars$2.01+0.5%N/A-38.8%$58.61M$490K-1.2140QNTMQuantum BiopharmaN/A$19.86-1.9%N/AN/A$58.05MN/A-1.25N/A Related Companies and Tools Related Companies Repare Therapeutics Alternatives Biomea Fusion Alternatives Achilles Therapeutics Alternatives Alto Neuroscience Alternatives Immix Biopharma Alternatives PDS Biotechnology Alternatives Sutro Biopharma Alternatives Adlai Nortye Alternatives VistaGen Therapeutics Alternatives Quantum Biopharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NKGN) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NKGen Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
